New York Life Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Buy
303,600
+565
+0.2% +$32.4K 0.12% 143
2026
Q1
$18.4M Buy
303,035
+7,860
+3% +$458K 0.16% 123
2025
Q4
$15.9M Sell
295,175
-1,734
-0.6% -$83.4K 0.14% 134
2025
Q3
$13.4M Sell
296,909
-18,333
-6% -$856K 0.12% 159
2025
Q2
$14.6M Buy
315,242
+4,450
+1% +$218K 0.14% 139
2025
Q1
$19M Sell
310,792
-4,731
-1% -$276K 0.19% 109
2024
Q4
$17.8M Buy
315,523
+4,219
+1% +$236K 0.17% 110
2024
Q3
$16.1M Sell
311,304
-9,881
-3% -$464K 0.16% 134
2024
Q2
$13.3M Buy
321,185
+3,261
+1% +$146K 0.13% 154
2024
Q1
$17.2M Sell
317,924
-11,350
-3% -$578K 0.17% 113
2023
Q4
$16.9M Sell
329,274
-5,546
-2% -$291K 0.17% 113
2023
Q3
$19.4M Sell
334,820
-4,346
-1% -$266K 0.21% 88
2023
Q2
$21.7M Sell
339,166
-2,358
-0.7% -$158K 0.23% 81
2023
Q1
$23.7M Buy
341,524
+766
+0.2% +$54K 0.26% 76
2022
Q4
$24.5M Sell
340,758
-92
-0% -$6.94K 0.28% 71
2022
Q3
$24.2M Buy
340,850
+431
+0.1% +$31.3K 0.29% 65
2022
Q2
$26.2M Buy
+340,419
New +$25.9M 0.3% 65

Other funds holding BMY

New York Life Investment Management's BMY Position: Q2 2026 in Review

New York Life Investment Management increased its Bristol-Myers Squibb (BMY) stake by 0.19% in Q2 2026, buying an estimated $32.4K and bringing the position to 303,600 shares worth $17.5M. The position accounts for 0.12% of the portfolio, ranked #143.

New York Life Investment Management first reported a position in BMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $26.2M in Q2 2022. 1,717 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • New York Life Investment Management held 303,600 shares of Bristol-Myers Squibb worth $17.5M as of Q2 2026.
  • New York Life Investment Management bought 565 Bristol-Myers Squibb shares in Q2 2026, an estimated $32.4K.
  • Bristol-Myers Squibb made up 0.12% of New York Life Investment Management's portfolio in Q2 2026, its #143 holding.
  • New York Life Investment Management first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Bristol-Myers Squibb position peaked at $26.2M in Q2 2022.
  • 1,717 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.